Skip to main content

Biomarkers

  • Reference work entry
Encyclopedia of Systems Biology
  • 518 Accesses

Synonyms

Biological marker; Molecular marker; Surrogate endpoint

Definition

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention (Biomarkers Definitions Working Group 2001). A biomarker can be used as an indicator of a change or, if it meets the highest standard of proof, a surrogate endpoint that is expected to predict clinical benefit (or harm, or lack of benefit or harm) based on epidemiologic, therapeutic, pathophysiologic, or other scientific evidence.

Biomarkers are widely used in medicine, drug discovery and development, and safety assessment. They serve as indicators for disease progression (diagnosis and prognosis), therapeutic responses (efficacy), and adverse side effects (safety) in organisms, organs, and/or cells. An ideal clinical biomarker should contain the following characteristics (Lesko and Atkinson 1999): (1) clinical...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95

    Google Scholar 

  • Goodsaid FM, Frueh FW, Mattes W (2008) Strategic paths for biomarker qualification. Toxicology 245:219–223

    PubMed  CAS  Google Scholar 

  • Lesko LJ, Atkinson AJ Jr (1999) Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol 41:347–366

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donna L. Mendrick .

Editor information

Editors and Affiliations

Additional information

Disclaimer: The views presented in this article do not necessarily reflect those of the US Food and Drug Administration.

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this entry

Cite this entry

Mendrick, D.L., Tong, W. (2013). Biomarkers. In: Dubitzky, W., Wolkenhauer, O., Cho, KH., Yokota, H. (eds) Encyclopedia of Systems Biology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9863-7_211

Download citation

Publish with us

Policies and ethics